News
Zacks.com on MSN2mon
GSK Beats on Q4 Earnings & Sales, Stock Up on Raised Long-Term OutlookGSK plc GSK reported fourth-quarter 2024 core ... Sales of Trelegy Ellipta and Flixotide/Flovent surged 17% and 47%, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback